![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/25 | |
A61K 38/00 |
(11) | Number of the document | 2012809 |
(13) | Kind of document | T |
(96) | European patent application number | 07752724.0 |
Date of filing the European patent application | 2007-03-09 | |
(97) | Date of publication of the European application | 2009-01-14 |
(45) | Date of publication and mention of the grant of the patent | 2013-05-22 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2007/006042 |
Date | 2007-03-09 |
(87) | Number | WO 2007/106385 |
Date | 2007-09-20 |
(30) | Number | Date | Country code |
781172 P | 2006-03-10 | US |
(72) |
TULIPANO, Giovanni, IT
GIUSTINA, Andrea, IT
DONG, Zheng, Xin, US
CULLER, Michael, Dewitt, US
|
(73) |
IPSEN PHARMA,
65 Quai Georges Gorse, 92100 Boulogne-Billancourt,
FR
|
(54) | USE OF A GHRELIN AGONIST TO IMPROVE THE CATABOLIC EFFECTS OF GLUCOCORTICOID TREATMENT |
USE OF A GHRELIN AGONIST TO IMPROVE THE CATABOLIC EFFECTS OF GLUCOCORTICOID TREATMENT |